going to be a lot of cash burn that will out pace revenues for at least 3 more years. Still.....it's a prove commercial technology. These would be the best levels to buy it at and check back in 2 years from now.
It won't be earnings releases that will bolster the share price anytime soon, rather an announcement that Medicare is coming on board, which is going to happen, and will be the biggest catalyst for this company.
That could happen in the next 18 months.
News 
Market Data 
Discover 
